Day 1 - Saturday, 25 May 2019
Topics
Meeting category
Date(s)
25 Sep 2019 - 26 Sep 2019
Organizer
Titanium Level Support
Sponsor logos
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Related Enduring Materials
Enduring Materials
Downloads:
Program
Session 1: HIV/AIDS in China -
Chairs
Yongtao Sun, MD
Tangdu Hospital, Xi’an, China
Wei Lyu
-
09:15
Study on HIV Variation and Evolution and Its Impact on Molecular Epidemiology and Drug Resistance Surveillance
09:40
Guidelines for Diagnosis and Treatment of HIV/Aids in China (2018)
Session 2: Prevention of HIV-infection -
Chairs
Hao Wu
-
Yaokai Chen
-
10:35
HIV Pre-Exposure Prophylaxis (PrEP)
11:00
PrEP Uptake Preferences Among Men Who Have Sex With Men in China: Results From a National Internet Survey
Session 3: Antiviral Therapy & Cure -
Chairs
Biao Zhu
-
13:50
HIV Drug Resistance
14:15
Novel Treatment Strategies - Two Versus Three Drugs
14:40
Progress Review on HIV Cure
Session 4: Clinical Management of HIV Coinfections -
Chairs
Yun He
-
Hongxia Wei
-
15:50
HIV/TB Co-infection in China
16:15
Clinical Characteristics and Prognostic Factors of Cryptococcal Meningitis Among HIV-Infected Patients
16:40
Clinical Management of HIV-HBV and HIV-HCV Coinfection
Day 2 - Sunday, 26 May 2019
Session 5: Progress in HBV treatment - 09:00
09:00
Progress on HBV treatment
Jinlin Hou, MD
Nanfang Hospital, Southern Medical University, China
09:25
HBV-Infection in Immune Compromised People
09:50
Novel Biomarkers for Chronic Hepatitis B
11:00
Update of Chronic Hepatitis B With Fatty Liver
11:25
Acute on Chronic Liver Failure - the Progress and My Experience
13:00
Satellite Symposium: Adaptable Best Practice Service Models for HIV & Viral Hepatitis
Scott McGill
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine Australia
14:00
The Advanced Technology of MDR-TB Diagnosis
Session 6: Progress in HCV Treatment -
Chair
Lingyun Shao
-
14:25
HCV Epidemiology
14:50
Hepatitis C Therapy: Unique Issues and Challenges in Asia
Pei-Jer Chen, MD, PhD
Nation Taiwan University College of Medicine Institute of Molecular Medicine
15:15
The Superinfection of Hepatitis E Virus in Chronic Hepatitis Patients
Session 7: Progress in Viral Hepatitis Cure/Elimination - 16:20
16:20
Progress in HBV Cure Research
Jidong Jia, MD, PhD
Beijing Friendship Hospital, Capital Medical University, China
16:45
Progress in HCV Cure / HCV Elimination
Overview
Welcome
The 8th Asian Conference on Hepatitis and AIDS (ACHA) took place on 25 and 26 May 2019 in Shanghai, China. Around 400 delegates participated in this very successful conference.
The Organizing Committee would like to thank all invited speakers and participants for their contribution to this conference!
We would like to thank our supporters!
Local Chair 2019
General Information
Unique Features
- A program with a special focus on the needs in China and Asia
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
- A true scientific platform for local and regional clinicians and clinical researchers to present their data
- A unique opportunity for regional clinicians, researchers, and pharmaceutical companies to meet and collaborate
Meeting Objectives
This meeting aims to:
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
- Provide education on the latest treatment options for HBV, HCV, HIV and associated co-infections
- Present the latest research data, especially in the Asian context and translate knowledge into clinical practice
- Provide a platform for interaction and dialogue among different disciplines and facilitate collaborations among local, national and regional communities
Learning Objectives
After participating in this activity, participants will be able to:
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
- Summarize the most recent results in drug development (including most recent clinical trial results) for HBV, HCV, and HIV
- Integrate the latest scientific results into daily clinical care to improve the treatment quality for HBV, HCV and HIV-positive individuals
Practical Information
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Committees
Chairs
Zhiliang Gao
MD, PhD
Organizing Committee
Charles Boucher
MD, PhD
Jidong Jia
MD, PhD
Hui Zhang
MD
Wei Lai
MD
Jinlin Hou
MD
Zhongping Duan
MD, PhD
Taisheng Li
MD, PhD
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
David Back
PhD, University of Liverpool, UK
Yi-Ming (Arthur) Chen
MD, National Yang-Ming University, Taiwan
Ishwar Gilada
MD, DDV, FCPS
Chien-Ching Hung
MD, PhD
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Titanium Level
Media
Image
Language
Related Programs
